Scinai Immunotherapeutics Appoints New Head of Supply Chain
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is bolstering its contract development and manufacturing operations with the appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration. This move aims to enhance operational infrastructure and support the scaling of its expanded CDMO platform. The company is focused on building robust systems to manage growth and improve coordination across its facilities.
* Scinai Immunotherapeutics () bolsters operational capacity with a key executive hire, aiming to support platform expansion and scalability.